https://bestanxietycrystals.com/maybe-shes-born-with-it-maybe-its-clinical-depression/
A medicine widely used to treat attention-deficit/hyperactivity disorder also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a trial led by St. Jude Children’s Research Hospital. Researchers reported that one year after starting the drug methylphenidate, young cancer survivors scored better on tests of sustained attention and other measures of attention, social skills and behavior than did a similar group of unmedicated survivors. Heather Conklin, Ph.D., of the St. Jude Psychology department, is the first author of the research published in the Journal of Clinical Oncology.
For more information:
5
t
A medicine widely used to treat attention-deficit/hyperactivity disorder also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a trial led by St. Jude Children’s Research Hospital. Young cancer survivors performed better than unmedicated patients in tests of sustained attention and other measures related to attention, social skills, and behavior one year after they started methylphenidate. Heather Conklin, Ph.D. from the St. Jude Psychology Department, is the first to publish the research in the Journal of Clinical Oncology.
For more information, visit
5
t
Product Description Undated ✓ ✓ ✓ ✓ ✓ ✓ Habit Tracker ✓ ✓ ✓ ✓ ✓ ✓ Academic Goals ✓ ✓ ✓ ✓ ✓ Password Manager No No No No ✓ ✓ Weekly Reflectio...